Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders

Medical cannabinoid products are widely used in Canada to treat medical symptoms of all kinds, and gastrointestinal (GI) symptoms are among the most commonly cited reasons for use (1). Cannabis…

Continue ReadingCanadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders

Cannabinoids for gastrointestinal diseases: potential therapeutic applications

Δ9-Tetrahydrocannabinol (the active ingredient of marijuana), as well as endogenous and synthetic cannabinoids, exert many biological functions by activating two types of cannabinoid receptors, CB1 and CB2 receptors. CB1 receptors have been detected…

Continue ReadingCannabinoids for gastrointestinal diseases: potential therapeutic applications